130 related articles for article (PubMed ID: 16209992)
1. Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy.
Tang W; Arnett DK; Devereux RB; Panagiotou D; Province MA; Miller MB; de Simone G; Gu C; Ferrell RE
Am Heart J; 2005 Oct; 150(4):845-51. PubMed ID: 16209992
[TBL] [Abstract][Full Text] [Related]
2. Association of CnB 5I/5D promoter gene polymorphism and serum calcineurin levels in early onset of coronary artery disease of south Indian cohort.
Maddhuri S; Bandaru S; Bhukya C; Cingeetham V; Malempati AR; Deepika MLN; Nallari P; Mundluru HP
Gene; 2017 Oct; 632():1-6. PubMed ID: 28827117
[TBL] [Abstract][Full Text] [Related]
3. Association of the rs3039851 Insertion/Deletion in the Gene
Gorący I; Łoniewska B; Lewandowska K; Boroń A; Grzegorczyk M; Nowak R; Clark JSC; Ciechanowicz A
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239086
[TBL] [Abstract][Full Text] [Related]
4. [The influence of calcineurin gene polymorphism on morphofunctional characteristics of cardiovascular system of athletes].
Akhmetov II; Linde EV; Shikhova IuV; Popov DV; Missina SS; Vinogradoba OL; Rogozkin VA
Ross Fiziol Zh Im I M Sechenova; 2008 Aug; 94(8):915-22. PubMed ID: 18825932
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study.
Palmieri V; Wachtell K; Bella JN; Gerdts E; Papademetriou V; Nieminen MS; Dahlöf B; Roman MJ; Devereux RB
J Hum Hypertens; 2004 Jun; 18(6):423-30. PubMed ID: 15002006
[TBL] [Abstract][Full Text] [Related]
6. [Polymorphic markers I/D and G7831A of angiotensin-I-converting enzyme gene and left ventricular hypertrophy in patients with essential hypertension].
Brazhnik VA; Gorashko NM; Minushkina LO; Zateĭshchikov DA; Zateĭshchikova AA; Nosikov VV; Sidorenko BA
Kardiologiia; 2003; 43(2):44-9. PubMed ID: 12891272
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension.
Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R
Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826
[TBL] [Abstract][Full Text] [Related]
9. Physical Activity Is Associated With Reduced Left Ventricular Mass in Obese and Hypertensive African Americans.
Kamimura D; Loprinzi PD; Wang W; Suzuki T; Butler KR; Mosley TH; Hall ME
Am J Hypertens; 2017 Jun; 30(6):617-623. PubMed ID: 28369190
[TBL] [Abstract][Full Text] [Related]
10. The CTGF gene -945 G/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes.
Patel SK; Wai B; Macisaac RJ; Grant S; Velkoska E; Ord M; Panagiotopoulos S; Jerums G; Srivastava PM; Burrell LM
Cardiovasc Diabetol; 2012 Apr; 11():42. PubMed ID: 22533709
[TBL] [Abstract][Full Text] [Related]
11. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Li ZB; Wachtell K; Okin PM; Gerdts E; Liu JE; Nieminen MS; Jern S; Dahlöf B; Devereux RB
J Hum Hypertens; 2004 Jun; 18(6):397-402. PubMed ID: 15071485
[TBL] [Abstract][Full Text] [Related]
12. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
Okin PM; Wright JT; Nieminen MS; Jern S; Taylor AL; Phillips R; Papademetriou V; Clark LT; Ofili EO; Randall OS; Oikarinen L; Viitasalo M; Toivonen L; Julius S; Dahlöf B; Devereux RB
Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
[TBL] [Abstract][Full Text] [Related]
14. Angiotensinogen M235T polymorphism and left ventricular indices in treated hypertensive patients with normal coronary arteries.
Olcay A; Nişanci Y; Ekmekçi CG; Ozbek U; Sezer M; Umman B; Buğra Z
Anadolu Kardiyol Derg; 2007 Sep; 7(3):257-61. PubMed ID: 17785212
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
16. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
[TBL] [Abstract][Full Text] [Related]
17. Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.
Bahramali E; Rajabi M; Jamshidi J; Mousavi SM; Zarghami M; Manafi A; Firouzabadi N
BMJ Open; 2016 Feb; 6(2):e010282. PubMed ID: 26861937
[TBL] [Abstract][Full Text] [Related]
18. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.
de Simone G; Kitzman DW; Palmieri V; Liu JE; Oberman A; Hopkins PN; Bella JN; Rao DC; Arnett DK; Devereux RB
Am J Hypertens; 2004 Sep; 17(9):828-33. PubMed ID: 15363827
[TBL] [Abstract][Full Text] [Related]
19. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
[TBL] [Abstract][Full Text] [Related]
20. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
